U.S. SECURITIES AND EXCHANGE COMMISSION
     Washington, D.C. 20549

     FORM 10-QSB

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2000

     OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File Number 01-8929

               SANITARY ENVIRONMENTAL MONITORING LABS, INC.
_________________________________________________________________
(Exact name of small business issuer as specified in its charter)

         Nevada                           13-3432594
(State or other jurisdiction of         (I.R.S. Employer
 incorporation or organization)         Identification No.)

  1408 Pawnee Drive, Las Vegas, Nevada          89102
(Address of principal executive offices)      (Zip Code)

      (888) 355-8805
  (Issuer's telephone number, including area code)

              N/A

(Former name, former address and former fiscal year, if changed
since last report)

Check whether the Issuer (1) filed all reports required to be
filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.     Yes __   No  X

The aggregate number of shares outstanding of the Issuer's Common
Stock, its sole class of common equity, was 11,603,827 as of
September 30, 2000.


Part 1

Item 1.  FINANCIAL STATEMENTS

               SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                      (A Development Stage Company)
                                 UNAUDITED
                              BALANCE SHEETS
                     September 30, 1999 and 2000

                                  ASSETS

                                        Sept. 30,      Sept. 30,
                                          2000          1999

Current Assets
 Cash                                     $ 19,141         721
 Accounts Receivable                             0           0
 Notes Receivable                           10,000           0
 Inventories/Supplies                       72,252           0
 Pre-paid expenses                               0           0

     Total Current Assets                $ 101,393         721

Fixed Assets                                     0           0
 Less Accumulated Depreciation                   0           0

     Total Fixed Assets                          0         721

     Total Assets                        $ 101,393         721
                                         ---------      ------

                                  LIABILITIES

Current Liabilities
 Accounts Payable                         $ 17,637   $  20,354
 Notes Payable                               4,127           0
 Litigation Reserve Payable                 65,000           0
 Due to Related Party (Note 5)           1,168,180      72,096
 Accrued Salaries                                0           0
                                           -------    --------
     Total Current Liabilities          $1,254,944   $  92,450

Long-Term Liabilities
 Notes Payable-Noncurrent                   50,000           0
                                         ---------   ---------
     Total Long-Term Liabilities            50,000           0

Stockholders' Deficit
 Common Stock, $.001 par value,
  authorized 50,000,000 shares,
  issued and outstanding
  2,553,827 in 1999 and 9,603,827           25,538      25,538
 Additional Paid-In Capital              7,984,901   7,777,260
 Retained Earnings                      (8,095,670) (7,884,958)

  Net Income                            (1,118,319)        0

  Total Capital                         (1,203,551)


     Total Liabilities and Equity         (101,393)       721
                                         =========  =========


Shares Outstanding                      11,603,827  2,553,827

<PAGE>
<TABLE> format change
                          SANITARY ENVIRONMENTAL MONITORING LABS, INC
                                  (A Development Stage Company)

                                         UNAUDITED
                                  STATEMENTS OF OPERATIONS
                            FOR THE THREE MONTHS ENDED SEPTEMBER 30, 1999
                        AND 2000 AND YEAR TO DATE SEPTEMBER 30, 1999 AND 2000

<S>                               <C>            <C>              <C>           <C>

                                     Three Months Ended                Year to Date
                                     ------------------              ----------------
                                           Sept. 30                        Sept. 30
                                           -------                         -------
                                     2000           1999             2000          1999
                                     ----           ----             ----          ----
Revenues
 Consulting Services              $  3,809       $       0        $ 23,109      $      0

Operating Expenses:
  Rent or Lease Expense              7,722               0         153,472             0
  Salaries and Wages Expense        35,900               0         634,395             0
  Equipment & Supplies Expense       2,639               0           9,578             0
  Interest Expense                  26,376               0         209,577             0
  Commissions and Fees Exp          31,123               0          62,088             0
  General and Administrative        53,458           8,571         102,321        17,142
                                  --------        --------       ---------      --------
     Total Expenses                157,218           8,571       1,171,431        17,142
                                  --------        --------       ---------      --------

Other Expenses:                          0               0               0             0

Net (loss)/Income                 (123,407)         (8,571)     (1,118,320)      (17,142)

Earnings per Common Share:
(Loss) from Operations Before
 Extraordinary items               (0.0106)      (0.0034)          (0.01)         (0.01)


Weighted-Average Number of Common
 shares Outstanding Used in Basic
 Earnings-per-Share calculation   11,603,827    2,553,827       11,603,827     2,553,827





</TABLE>

<PAGE>
<PAGE>

               SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                     (A Development Stage Company)
                               UNAUDITED
                       STATEMENT OF CASH FLOWS
                     FOR THE THREE MONTHS ENDED
               SEPTEMBER 30, 2000 AND FOR THE THREE MONTHS
                        ENDING SEPTEMBER 30, 1999


                                  3 Months              3 Months
                                  Ended                 Ended
                                  Sept.                 Sept.
                                  30, 2000              30, 1999

Operating Activities:
  Net Loss                       $(123,407)            $  (8,571)

Adjustments to Reconcile Net
  Net Loss to Cash Used in
  Operating Activities
  Increase (Decrease) in:
   Inventory-Equipment              (4,337)                    0
   Notes Payable                   (10,000)                    0
   Due to related parties (note 5)  54,324                 8,571
   Extraordinary item-litigation         0                     0
                                   -------                ------
Cash Used in Operating Activities   30,089                     0
                                   -------                ------
Cash loss by Operating Activities  (93,318)                    0
                                   --------               ------

Cash Flows from Financing Activities
    Notes Payable-Noncurrent        50,000
    Paid-in Capital                      0                     0
    Rounding                             0                     0
                                   -------                ------
Cash used in Financing Activities   50,000                     0
                                   -------                ------
Net Increase (Decrease) in Cash    (43,318)                    0
                                    ======                ======

Summary Cash

   Beginning Cash                   62,460                   721
   Ending Cash                      19,142                   721
                                    ------                ======
 Net Increase (Decrease) in Cash   (43,318)                    0
                                    ======                ======

<PAGE>
<TABLE>
          STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
                     FOR THE YEAR ENDED 1999
             AND THE QUARTER ENDED SEPTEMBER 30, 2000


                  Common Stock       APIC        Accumulated  Stockholder
                  Shares    Amount   Amount       (Deficit)   (Deficit)
                  -------------------------------------------------------
<S>
Balance December  <C>       <C>      <C>         <C>           <C>
31, 1999          2,553,827 $25,538  $7,777,260  $(7,975,670)  $(172,872)

 Issuance of shares
 first quarter    7,050,000 $70,500     409,000                  582,500

 Net loss
   1st Quarter                                     (  904,689)   (904,689)

Balance at
 March 31, 2000   9,603,827  96,038   8,286,260   (8,880,359)   (498,061)

 Net loss
   2nd Quarter                                     (   90,223)   ( 90,223)
                  --------- -------   ---------   ----------     -------
Balance at
 June 30, 2000    9,603,827  96,038   8,286,260   (8,970,582)   (588,284)

 Issuance of shares
 third quarter    2,000,000  20,000     480,000      500,000     500,000

 Net loss
 third quarter                                    (  123,407)   (123,407)
                  --------- -------   ---------    ---------      ------
Balance at
 Sept. 30, 2000  11,603,827 116,038   8,766,260   (8,593,989)   (211,691)




</TABLE>
<PAGE>

<PAGE>
Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
         FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THE COMPANY

Background.    Israel Semiconductor Corporation, as of March 31,
1999, had fully liquidated its only subsidiary and asset, GAD
Semiconductors, and was actively seeking new business ventures.
This search resulted in the identification of SemcoLabs, Inc., a
Florida corporation and the then-represented business of testing
restaurants for bacterial safety, and a corporate combination
agreement, executed in September of 1999 and tentatively
concluded in November of that year.

Business Development.  The company, having originally entered
into the merger agreement in September of 1999, ultimately
determined that the consideration alleged to have been delivered
in that agreement was invalid and insufficient, and rescinded the
agreement for share issuance and corporate acquisition.  This
resulted in the cancellation of approximately 19,400,000
restricted common shares and return of any assets and/or rights
to SemcoLabs, Inc., the Florida corporation, effective February
10, 2000.  Thereafter, in order to preclude litigation claims by
private investors that invested $200,000 in Semcolabs (prior to
any merger or acquisition by this company), the company agreed to
acquire $200,000 of Semco (Florida) debt liability in exchange
for the rights to Semco (Florida)'s wholly owned subsidiary,
Semco Bio-Vision, which basically contained certain name
trademark and tradename registrations and no other assets.  This
was accomplished in late February and resulted in the issuance of
2,650,000 shares of the company's common stock to satisfy the
claims of the $200,000 in liabilities absorbed with the
Bio-Vision acquisition.

Prior to that time, the company eliminated its then-existing
obligations to its legal counsel by the issuance of 150,000
shares of restricted common stock, and obtained a minor amount of
working capital ($62,500) by selling 250,000 shares of restricted
stock to Mesa, Inc., in a private placement, which also included
250,000 warrants, exercisable at any time in the succeeding three
years, at an exercise price of $1.00 per share.

On February 15, 2000, the company approved a tentative exclusive
sub-license rights contract with Monaco Investment Group, Ltd.,
which was in the process of securing the exclusive licensing
rights for use of the Merck Hi-Liter II technology in the United
States, by pledging $1,000,000 in orders.  Monaco agreed to
license these rights to the Company without any pre-commitment
but with a dollar-derived minimum purchase amount, measured on an
annual basis.  The company agreed to issue 4,000,000 shares of
its restricted common stock to obtain a 5-year exclusive
sub-license of these rights in the United States so long
as certain minimum purchase requirements were met and Monaco
delivered the exclusive sub-license.  This did not occur until
May of 2000.

The company also committed to repay certain loans made by an
officer/director of the company in the total amount of
$1,060,867, plus interest, or, alternatively, allowing a
cancellation of the indebtedness by conversion of the debt into
company common stock at the rate of $0.25 per share, this right
to remain open for a period of 5 years from the date of the
agreement (March 28, 2000).  This commitment to repay was entered
into the first quarter's balance sheet, resulting in a one-time
loss of $904,689 recognized during this reporting period.

Capital Resources and Liquidity.

Other than the $62,500 raised by the private placement to Mesa,
Inc., the company had no capital infusion and collected no fees
for provision of any services.  This sum allowed the company to
meet its obligation during the first quarter and have
approximately $6,000 in cash on hand at the end of the quarter,
with $10,000 in accounts receivable, although the company did
engender a non-debt-repayment related loss of $53,057 for the
quarter.

On June 23, 2000, the Company entered into a Subscription
Agreement with Girardi Financial whereby Girardi would loan the
Company $500,000 so long as it obtained favorable conversion
rights in the future.  This loan was accepted, funded in early
July, and converted into equity on August 3, 2000 by the issuance
of 2,000,000 shares of restricted stock.

During the third quarter, revenue from consulting diminished,
while expenses increased slightly, resulting in a net loss of
$123,047 for the quarter.  This was primarily the result of the
hiring of additional sales and marketing staff.

No other financing activity took place during this quarter.

<PAGE>
<PAGE>
Part II.  Other Information

     Item 1.   Legal Proceedings

               None

     Item 2.   Changes in Securities

      The company issued convertible debt to repay certain loans
made to the company in the total amount of $500,000, allowing a
cancellation of the indebtedness by conversion of the debt into
company common stock at the rate of $0.25 per share, which
occurred on August 3,2001.

     Item 3.   Default Upon Senior Securities

               None

     Item 4.   Submission of Matters to a Vote of Security
                 Holders

               None

     Item 5.   Other Information

               None

     Item 6.   Exhibits and Reports On Form 8K

               Girardi note filed as Exhibit 10.10 with 1999
10KSB.

<PAGE>
<PAGE>

    SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of
1934, Registrant has duly caused this Report to be signed on its
behalf by the undersigned, thereunto duly authorized.


                   SANITARY ENVIRONMENTAL MONITORING LABS, INC.
                               (Registrant)

                              By:          /s/  Robert M. Terry
                                             Robert M. Terry,
                                             Chairman


Dated:  May 15, 2001